ReviewCureus2025
Prognostic Tools for Predicting Mortality in Older Adults With Hip Fracture: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Serial Presepsin Measurement as a Predictor of In-Hospital Mortality in Older Adults with Hip Fractures.Life (Basel, Switzerland) · 2026Article
- Prognostic nutritional index at admission predicts 90-day mortality in patients aged ≥80 years with hip fracture: a system-level readout of the nutrition-immune milieu relevant to microenvironment-responsive bone repair.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hip fracture (HF) is highly prevalent in older adults and is associated with functional impairment, disability, institutionalisation, increased use of healthcare resources, and mortality. Knowing the prognostic tools and identifying a gold standard to unify criteria would allow for more personalised clinical decision-making. The aim of this study is to conduct a systematic review of prognostic tools and their ability to predict mortality in patients over 65 years of age with HF. A search was conducted in the PubMed, Scopus, and Web of Science databases for studies published up to June 2022. The eligibility criteria were single-centre or multicentre studies published in English or Spanish that assessed the predictive ability of a prognostic tool for long-term mortality in patients over 65 years of age with HF. We identified 24 eligible publications. Most were single-centre observational cohort studies; 13 were prospective. The prognostic tools that showed better predictive capacity for 30-day mortality were the ASA score, age, cognitive status, gender, and Charlson Comorbidity Index score (ASAgeCoGeCC score) and the Almelo Hip Fracture Score (age, gender, haemoglobin, cognitive status, comorbidities, malignancy, mobility score, and ASA score), both with an area under the curve (AUC) of 0.82. The best predictive capacity for six-month mortality (AUC = 0.83) was reported for a nomogram that included age; albumin, sodium, and haemoglobin values; and Charlson Comorbidity Index score. The Frail-VIG index (including five domains: clinical, nutritional, functional, cognitive, and social) had the highest predictive capacity for one-year mortality (AUC = 0.90). There is great variability in tools for predicting mortality in patients with HF. Those that have greater predictive capacity include a multidimensional assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.